Retrophin Doses First Patient in Pivotal Phase 3 PROTECT Study of Sparsentan for the Treatment of IgA Nephropathy Pharmaceutical Investing
BeyondSpring Announces Positive Pre-NDA Meeting with the U.S. FDA for its Lead Asset, Plinabulin Pharmaceutical Investing
Isodiol International Inc. Comments on U.S. Farm Bill; Provides Update on Canadian Assets Biotech Investing
MediPharm Labs Increases Annual Production Capacity by 50% Up to 150,000KG; Positioned to Meet Significant Demand for Purified Cannabis Concentrates and Oil Cannabis Investing News
Life Science Big News Roundup: Therma Bright Inc. Issues Update on Pain Relief Device and TherOZap(TM) Technology; Cardiol Therapeutics Completes Initial Public Offering Life Science Investing
ARCA biopharma Updates Special Protocol Assessment Request to FDA for Gencaro Phase 3 Atrial Fibrillation Clinical Trial Biotech Investing
Green Growth Brands Recognizes Monumental Policy Shift With Passage of 2018 Farm Bill Cannabis Investing News
